Cargando…
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
Repurposing of the anthelminthic drug niclosamide was proposed as an effective treatment for inflammatory airway diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease. Niclosamide may also be effective for the treatment of viral respiratory infections, such as SARS-CoV-...
Autores principales: | Ousingsawat, Jiraporn, Centeio, Raquel, Cabrita, Inês, Talbi, Khaoula, Zimmer, Oliver, Graf, Moritz, Göpferich, Achim, Schreiber, Rainer, Kunzelmann, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835663/ https://www.ncbi.nlm.nih.gov/pubmed/35163010 http://dx.doi.org/10.3390/ijms23031085 |
Ejemplares similares
-
Calmodulin-Dependent Regulation of Overexpressed but Not Endogenous TMEM16A Expressed in Airway Epithelial Cells
por: Talbi, Khaoula, et al.
Publicado: (2021) -
SLC26A9 in airways and intestine: secretion or absorption?
por: Kunzelmann, Karl, et al.
Publicado: (2023) -
KCNE1 does not shift TMEM16A from a Ca(2+) dependent to a voltage dependent Cl(-) channel and is not expressed in renal proximal tubule
por: Talbi, Khaoula, et al.
Publicado: (2023) -
Expression of SLC26A9 in Airways and Its Potential Role in Asthma
por: Ousingsawat, Jiraporn, et al.
Publicado: (2022) -
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
por: Centeio, Raquel, et al.
Publicado: (2021)